Champions Oncology Inc. Company Profile
NASDAQ: CSBRHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Champions Oncology at a glance
Champions Oncology Inc. (NASDAQ: CSBR) is a Biotechnology company in the Healthcare sector headquartered in Hackensack, NJ. Champions Oncology is led by Mr. Robert Brainin and employs about 214 people. At a market capitalization of $69.3 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0000771856, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Champions Oncology do?
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- Champions Oncology Inc.
- Ticker
- NASDAQ: CSBR
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Robert Brainin
- Employees
- 214
- Headquarters
- One University Plaza, Hackensack, NJ, United States
- Phone
- 201 808 8400
- Website
- championsoncology.com
- Market cap
- $69.31M
- SEC CIK
- 0000771856
Companies similar to Champions Oncology
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TENXTenax Therapeutics Inc. | 1.86 | -2.62% | $69.61M | vs CSBR |
| FBIOFortress Biotech Inc. | 2.09 | +2.45% | $69.70M | vs CSBR |
| GANXGain Therapeutics Inc. | 1.62 | -3.29% | $70.48M | vs CSBR |
| HRTXHeron Therapeutics Inc. | 0.3582 | -6.79% | $68.01M | vs CSBR |
| CINGCingulate Inc. | 4.88 | +0.21% | $70.96M | vs CSBR |
| MAIAMAIA Biotechnology Inc. | 1.15 | -2.54% | $71.00M | vs CSBR |
| HYFTMindWalk Holdings Corp. | 1.43 | -4.67% | $67.37M | vs CSBR |
| ONCYOncolytics Biotech Inc. | 0.5444 | -8.63% | $71.38M | vs CSBR |